60-plus population with co-morbidity will not require doctor certificate for precaution dose: Centre

New Delhi, December 28

People aged 60 years and above with co-morbidity will not be required to produce or submit any certificate from doctor at the time of administration of precaution dose of Covid-19 vaccine, the Centre told states and Union Territories on Tuesday.

Such persons are expected to obtain the advice of their doctor before deciding to avail of the precaution dose or third dose.

In a letter to states and UTs, Union Health Secretary Rajesh Bhushan said personnel to be deployed in election duty in the poll-bound states will be included in the category of frontline workers.

Eligibility of such beneficiaries for the precaution dose will be based on the date of administration of 2nd dose as recorded in the Co-WIN system—completion of nine months i.e. 39 weeks from the date of administration of second dose—Bhushan said.

He informed that CoWIN will send reminder messages to all those eligible for precaution dose, which will be reflected in digital vaccination certificates.

Bhushan chaired a workshop through video conference on Tuesday with all states and UTs to review the roll-out of vaccination for the age group 15-18 and precautionary third dose for vulnerable categories—healthcare workers (HCW), frontline workers (FLW) and those in the 60-plus age group with co-morbidity.

He said only Covaxin is to be administered in the age group 15-18 years and that additional doses of the vaccine will be sent to all states and UTs.

The Union Government will share the supply schedule of Covaxin with all the states and UTs in the next few days, he said.

Potential beneficiaries can either register themselves on Co-WIN from January 1 or avail of a walk-in registration when vaccination commences from January 3. Those with a birth year of 2007 or before will be eligible for vaccination under this category, he said.

All established protocols regarding vaccination are to be followed for the 15-18 years age group, beneficiaries are to wait for half-an-hour when they will be monitored for AEFI and will be eligible for the 2nd dose only after 28 days, according to a Health Ministry statement.

States were informed that they have the option to designate some Covid Vaccination Centre for vaccination of the 15-18 age group exclusively which can also be reflected on Co-WIN. Dedicated CVCs would ensure that there is no confusion in administering the vaccines.

For CVCs that are intended to serve all, the states were requested to ensure separate queues and vaccination teams for the 15-18 age group.

With regards to the administration of the precautionary dose, the Union Health Secretary highlighted that nine months must have elapsed since the administration of the second dose to make the beneficiary eligible.

Drawing attention to the misinformation being propagated through various media regarding the requirement of a doctor’s certificate to establish co-morbidity, he categorically emphasised that the Union government has not issued any directions on the matter and prescriptions/certificates are not mandated to be produced at the vaccination centre for administration of the precaution dose.

States and UTs were further advised to ensure the orientation of vaccinators and vaccination team members for vaccination of the 15-18 age group. States were exhorted to undertake proper planning in advance for distribution of Covaxin to identified session sites. To avoid the mixing-up of vaccines during administration, separate CVCs, separate session sites, separate queue and separate vaccination team are to be strived for.

All citizens irrespective of their income status are entitled to free Covid-19 vaccination at government vaccination centres, Bhushan said in a letter.

Those who have the ability to pay are encouraged to use private hospitals’ vaccination centres. The previously declared price for each vaccine at private centre will remain applicable for these group of beneficiaries, Bhushan said. —PTI

Join Whatsapp Channel of The Tribune for latest updates.